Prospectus Supplement
(To Prospectus dated April 28, 2021)
16,000,000 Shares
![LOGO](https://capedge.com/proxy/424B5/0001193125-21-323053/g172913g12z85.jpg)
4.750% Series C Cumulative Redeemable Preferred Stock
(Liquidation Preference $25.00 Per Share)
We are offering16,000,000 shares of our 4.750% Series C Cumulative Redeemable Preferred Stock, par value $0.01 per share, which we refer to in this prospectus supplement as the series C preferred stock. We will pay cumulative dividends on the series C preferred stock from the date of first issue of any shares of series C preferred stock at a rate of 4.750% per annum of the $25.00 liquidation preference per share (equivalent to an annual rate of $1.1875 per share). Dividends on the series C preferred stock will be payable quarterly in arrears on or about the last day of March, June, September and December of each year, beginning on or about March 31, 2022. The series C preferred stock will rank senior to our common stock with respect to dividend rights and rights upon our liquidation, dissolution or winding up.
Generally, we are not allowed to redeem the series C preferred stock prior to November 16, 2026 except in limited circumstances to preserve our status as a real estate investment trust, or REIT, and pursuant to the special optional redemption provision described below. On or after November 16, 2026 we may, at our option, redeem the series C preferred stock, in whole or in part, at any time or from time to time, for cash at a redemption price of $25.00 per share, plus all accrued and unpaid dividends on such series C preferred stock up to, but not including, the redemption date (other than any dividend with a record date before the applicable redemption date and a payment date after the applicable redemption date, which will be paid on the payment date notwithstanding prior redemption of such shares). In addition, upon the occurrence of a change of control, as a result of which neither our common stock, par value $0.01 per share, nor the common equity securities of the acquiring or surviving entity (or American Depositary Receipts, or ADRs, representing such securities) is listed on the New York Stock Exchange, or NYSE, NYSE American, LLC, or the NYSE AMER, or the NASDAQ Stock Market, or the NASDAQ, or listed or quoted on a successor exchange or quotation system, we may, at our option, redeem the series C preferred stock, in whole or in part, within 120 days after the first date on which such change of control occurred, by paying $25.00 per share, plus any accrued and unpaid dividends to, but not including, the date of redemption. If we exercise any of our redemption rights relating to the series C preferred stock, the holders of any shares of series C preferred stock called for redemption will not have the conversion right described below. The series C preferred stock has no stated maturity and is not subject to mandatory redemption at the option of the holder or any sinking fund. Holders of shares of series C preferred stock will generally have no voting rights except for limited voting rights if we fail to pay dividends for six or more quarterly periods (whether or not consecutive) and in certain other circumstances.
Upon the occurrence of a change of control, as a result of which neither our common stock nor the common securities of the acquiring or surviving entity (or ADRs representing such securities) is listed on the NYSE, the NYSE AMER or the NASDAQ, or listed or quoted on a successor exchange or quotation system, each holder of series C preferred stock will have the right (unless, on or prior to the Change of Control Conversion Date (as defined herein), we have provided or provide notice of our election to redeem such shares of series C preferred stock) to convert some or all of the series C preferred stock held by it into a number of shares of our common stock per share of series C preferred stock to be converted equal to the lesser of:
| • | | the quotient obtained by dividing (i) the sum of the $25.00 liquidation preference plus the amount of any accrued and unpaid dividends thereon to, but not including, the Change of Control Conversion Date (unless the Change of Control Conversion Date is after a record date for a series C preferred stock dividend payment and prior to the corresponding series C preferred stock dividend payment date, in which case no additional amount for such accrued and unpaid dividend will be included in this sum) by (ii) the Common Stock Price (as defined herein); and |
| • | | 1.9121, or the Share Cap, subject to certain adjustments; |
subject, in each case, to provisions for the receipt of alternative consideration as described in this prospectus supplement.
We are organized and conduct our operations to qualify as a REIT for federal income tax purposes. To assist us in complying with certain federal income tax requirements applicable to REITs, our charter contains certain restrictions relating to the ownership and transfer of our capital stock, including an ownership limit of 9.8% of the outstanding shares of series C preferred stock.
No market currently exists for the series C preferred stock. We intend to file an application to list the series C preferred stock on the NYSE under the symbol “HPP Pr C”. If the application is approved, trading of the series C preferred stock on the NYSE is expected to commence within 30 days after the date of initial delivery of the series C preferred stock.
Investing in the series C preferred stock involves a high degree of risk. Before buying any series C preferred stock, you should carefully read the discussion of material risks of investing in the series C preferred stock under “Risk Factors” beginning on page S-16 of this prospectus supplement and the risks set forth under the caption “Item 1A. Risk Factors” included in our most recent Annual Report on Form 10-K and in our subsequent Quarterly Reports on Form 10-Q, which are incorporated by reference herein.
| | | | | | | | |
| | Per Share | | | Total | |
Public offering price (1) | | $ | 25.0000 | | | $ | 400,000,000 | |
Underwriting discount (2) | | $ | 0.7875 | | | $ | 12,600,000 | |
Proceeds, before expenses, to us (3) | | $ | 24.2125 | | | $ | 387,400,000 | |
(1) | Plus accrued dividends, if any, from the original date of issue. |
(2) | Underwriting commissions of $0.7875 per share (or up to $12,600,000 for all shares of series C preferred stock) will be deducted from the proceeds paid to us by the underwriters. However, the commission are $0.50 per share for sales to institutions and, as a result of sales to institutions, the total proceeds to us increased by $2,404,635.62. We refer you to “Underwriting” beginning on page S-40 of this prospectus supplement for additional information regarding underwriting compensation. |
(3) | Assumes no exercise of the underwriters’ over-allotment option described below. |
We have granted the underwriters an option to purchase up to an additional 2,400,000 shares of series C preferred stock at the public offering price, less the underwriting discount, within 30 days from the date of this prospectus supplement solely to cover over-allotments, if any.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement and the accompanying prospectus are truthful or complete. Any representation to the contrary is a criminal offense.
The shares of series C preferred stock will be ready for delivery on or about November 16, 2021.
Joint Book-Running Managers
| | | | | | |
BofA Securities | | Morgan Stanley | | Wells Fargo Securities | | RBC Capital Markets |
|
Co-Managers |
Barclays | | BMO Capital Markets | | Fifth Third Securities |
Goldman Sachs & Co. LLC | | Regions Securities LLC | | Ramirez and Co., Inc. |
The date of this prospectus supplement is November 4, 2021